药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Indapamide
Relugolix
The risk or severity of QTc prolongation can be increased when Relugolix is combined with Acebutolol.
Indapamide
Fostemsavir
The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Acebutolol.
Indapamide
Lopinavir
The risk or severity of QTc prolongation can be increased when Lopinavir is combined with Acebutolol.
Indapamide
Posaconazole
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Acebutolol.
Indapamide
Lapatinib
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Acebutolol.
Indapamide
Chlorprothixene
The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Acebutolol.
Indapamide
Thiothixene
The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Acebutolol.
Indapamide
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Acebutolol.
Indapamide
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Acebutolol.
Indapamide
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Acebutolol.
Indapamide
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Acebutolol.
Indapamide
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Acebutolol.
Indapamide
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Acebutolol.
Indapamide
Triclabendazole
The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Acebutolol.
Indapamide
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Acebutolol.
Indapamide
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Acebutolol.
Indapamide
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Acebutolol.
Indapamide
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Acebutolol.
Indapamide
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Acebutolol.
Indapamide
Ebastine
The risk or severity of QTc prolongation can be increased when Ebastine is combined with Acebutolol.